842 filings
Page 2 of 43
4
Kaufman Beth Zelnick
14 Dec 23
CorMedix / Kaufman Beth Zelnick ownership change
4:05pm
3
Kaufman Beth Zelnick
14 Dec 23
CorMedix / Kaufman Beth Zelnick ownership change
4:05pm
4
Erin Mistry
21 Nov 23
CorMedix / Erin Mistry ownership change
4:00pm
4
CRMD
CorMedix Inc
17 Nov 23
CorMedix / Steven W Lefkowitz ownership change
4:50pm
8-K
CRMD
CorMedix Inc
16 Nov 23
CORMEDIX INC. ANNOUNCES FDA APProval of Defencath® To reduce
4:11pm
8-K
CRMD
CorMedix Inc
14 Nov 23
Cormedix Inc. Reports Third Quarter and Nine Month 2023 Financial Results and Provides Business Update
4:10pm
10-Q
2023 Q3
CRMD
CorMedix Inc
Quarterly report
14 Nov 23
12:00am
8-K
CRMD
CorMedix Inc
30 Oct 23
Submission of Matters to a Vote of Security Holders
4:35pm
ARS
2022 FY
CRMD
CorMedix Inc
13 Sep 23
Annual report to shareholders
5:26pm
DEFA14A
CRMD
CorMedix Inc
13 Sep 23
Additional proxy soliciting materials
5:25pm
DEF 14A
CRMD
CorMedix Inc
Definitive proxy
13 Sep 23
5:20pm
4
CRMD
CorMedix Inc
8 Sep 23
CorMedix / Joseph Todisco ownership change
4:21pm
8-K
CRMD
CorMedix Inc
17 Aug 23
Departure of Directors or Certain Officers
8:30am
10-Q
2023 Q2
CRMD
CorMedix Inc
Quarterly report
8 Aug 23
8:12am
8-K
CRMD
CorMedix Inc
8 Aug 23
CorMedix Inc. Reports SECOND Quarter AND SIX MONTH 2023 Financial Results and Provides Business Update
7:45am
8-K
CRMD
CorMedix Inc
30 Jun 23
Cormedix Inc. Announces Proposed Public Offering of Common Stock and Pre-funded Warrants
4:40pm
424B5
CRMD
CorMedix Inc
30 Jun 23
Prospectus supplement for primary offering
4:38pm
424B5
CRMD
CorMedix Inc
28 Jun 23
Prospectus supplement for primary offering
5:13pm
8-K
CRMD
CorMedix Inc
21 Jun 23
Cormedix Inc. Announces Fda Acceptance of Resubmission of New Drug Application for Defencath
8:42am
4
Kaplan Myron
19 May 23
CorMedix / Myron Kaplan ownership change
4:02pm